Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association Between Proton Pump Inhibitor Use and Risk of Fracture in Children
Yunhan Wang, Viktor Wintzell, Jonas F. Ludvigsson, et al.
JAMA Pediatrics (2020) Vol. 174, Iss. 6, pp. 543-543
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Proton Pump Inhibitors and Fracture Risk: A Review of Current Evidence and Mechanisms Involved
Benjamin Ka Seng Thong, Ima Nirwana Soelaiman, Kok‐Yong Chin
International Journal of Environmental Research and Public Health (2019) Vol. 16, Iss. 9, pp. 1571-1571
Open Access | Times Cited: 130
SAGES guidelines for the surgical treatment of gastroesophageal reflux (GERD)
Bethany J. Slater, Rebecca Dirks, Sophia K. McKinley, et al.
Surgical Endoscopy (2021) Vol. 35, Iss. 9, pp. 4903-4917
Closed Access | Times Cited: 86
Long-term use of proton pump inhibitors as a risk factor for various adverse manifestations
Arun Koyyada
Therapies (2020) Vol. 76, Iss. 1, pp. 13-21
Closed Access | Times Cited: 77
Association Between Proton Pump Inhibitor Use and Risk of Asthma in Children
Yunhan Wang, Viktor Wintzell, Jonas F. Ludvigsson, et al.
JAMA Pediatrics (2021) Vol. 175, Iss. 4, pp. 394-394
Open Access | Times Cited: 56
Proton Pump Inhibitor Use and Risk of Serious Infections in Young Children
Marion Lassalle, Mahmoud Zureik, Rosemary Dray‐Spira
JAMA Pediatrics (2023) Vol. 177, Iss. 10, pp. 1028-1028
Open Access | Times Cited: 39
A Narrative Review on Efficacy and Safety of Proton Pump Inhibitors in Children
Valeria Dipasquale, Giuseppe Cicala, Edoardo Spina, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 34
The evolution of nutrition management in children with severe neurological impairment with a focus on cerebral palsy
Stina Oftedal, Siobhan McCormack, Richard D. Stevenson, et al.
Journal of Human Nutrition and Dietetics (2024) Vol. 38, Iss. 1
Open Access | Times Cited: 6
Pediatric Prescriptions of Proton Pump Inhibitors in France (2009-2019): A Time-Series Analysis of Trends and Practice Guidelines Impact
Shuai Yang, Nhung T. H. Trinh, Martin Chalumeau, et al.
The Journal of Pediatrics (2022) Vol. 245, pp. 158-164.e4
Open Access | Times Cited: 26
A Review of Histamine-2 Receptor Antagonist and Proton Pump Inhibitor Therapy for Gastroesophageal Reflux Disease in Neonates and Infants
Jason Tan, Sonia Jeffries, Roxane Carr
Pediatric Drugs (2023) Vol. 25, Iss. 5, pp. 557-576
Closed Access | Times Cited: 15
Fracture Risk Linked to Proton Pump Inhibitors Versus H2 Receptor Antagonists in Autoimmune Rheumatic and Gastrointestinal Disease Patients
Miaoyu Zeng, Yung‐Heng Lee, Shiow‐Ing Wang, et al.
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 2
Closed Access
Why think twice before prescribing proton pump inhibitors
An-Sofie Lemmens, Koen Huysentruyt, Yvan Vandenplas
European Journal of Pediatrics (2025) Vol. 184, Iss. 3
Closed Access
Proton pump inhibitor use and risk of depression and anxiety in children: nationwide cohort study
Yun‐Han Wang, Viktor Wintzell, Jonas F. Ludvigsson, et al.
Clinical and Translational Science (2022) Vol. 15, Iss. 5, pp. 1112-1122
Open Access | Times Cited: 16
Proton pump inhibitors, bone and phosphocalcic metabolism
Cécile Philippoteaux, Julien Paccou, Emmanuel Chazard, et al.
Joint Bone Spine (2024) Vol. 91, Iss. 5, pp. 105714-105714
Closed Access | Times Cited: 3
Impact of highly effective modulator therapy on gastrointestinal symptoms and features in people with cystic fibrosis
Martina Cecchetti, Luca Scarallo, Paolo Lionetti, et al.
Paediatric Respiratory Reviews (2024)
Closed Access | Times Cited: 3
Novel Advances in the Evaluation and Treatment of Children With Symptoms of Gastroesophageal Reflux Disease
Rachel Rosen
Frontiers in Pediatrics (2022) Vol. 10
Open Access | Times Cited: 15
Proton Pump Inhibitors in Pediatric Gastroesophageal Reflux Disease: A Systematic Review of Randomized Controlled Trials
Sara María Fernández-González, Ana Moreno‐Álvarez, Alfonso Solar‐Boga
Children (2024) Vol. 11, Iss. 3, pp. 296-296
Open Access | Times Cited: 2
Esophagitis, treatment outcomes, and long‐term follow‐up in children with esophageal atresia
Anam Bashir, Amornluck Krasaelap, Dave R. Lal, et al.
Journal of Pediatric Gastroenterology and Nutrition (2024)
Closed Access | Times Cited: 2
Proton-Pump Inhibitors and Fat Absorption in Cystic Fibrosis and Pancreatic Insufficiency: A Randomized Crossover Pilot Trial
Anna Evans Phillips, Jefferson N. Brownell, Alyssa Tindall, et al.
Digestive Diseases and Sciences (2024)
Open Access | Times Cited: 2
The evolution of nutritional care in children with food allergies – With a focus on cow's milk allergy
Rosan Meyer, Marion Groetch, Alexandra F. Santos, et al.
Journal of Human Nutrition and Dietetics (2024) Vol. 38, Iss. 1
Open Access | Times Cited: 2
Acid suppression duration does not alter anastomotic stricture rates after esophageal atresia with distal tracheoesophageal fistula repair: A prospective multi-institutional cohort study
Alexis N. Bowder, Christina M. Bence, Beth Rymeski, et al.
Journal of Pediatric Surgery (2022) Vol. 57, Iss. 6, pp. 975-980
Closed Access | Times Cited: 11
Proton-pump inhibitor-induced bone loss is preventable by concomitant use of a long-acting somatostatin analogue.
Farhad Koohpeyma, Samaneh Taghiyan, Mesbah Shams
PubMed (2024) Vol. 27, Iss. 2, pp. 165-169
Closed Access | Times Cited: 1
Proton Pump Inhibitors in Pediatric Gastroesophageal Reflux Disease: A Systematic Review of Randomised Controlled Trials
Sara María Fernández-González, Ana Moreno‐Álvarez, Alfonso Solar‐Boga
(2024)
Open Access | Times Cited: 1
Prescriptions of anti‐reflux drugs in neonatology and neonatal intensive care units: A large multicentre observational study (2014–2022)
Manon Tauzin, Béatrice Gouyon, Jiao Liu, et al.
British Journal of Clinical Pharmacology (2024) Vol. 90, Iss. 12, pp. 3201-3211
Open Access | Times Cited: 1
A review of proton pump inhibitor use in cystic fibrosis and considerations for deprescribing
Nicole E. Omecene, Nicole Wilcox, Alexandra Cox, et al.
Pediatric Pulmonology (2024) Vol. 59, Iss. 12, pp. 3148-3158
Closed Access | Times Cited: 1
Calcium-based phosphate binder use is associated with lower risk of osteoporosis in hemodialysis patients
Hiroko Hashimoto, Satomi Shikuma, Shintaro Mandai, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top